Remiges Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
36
- Portfolio
-
22
- Exits
-
2
Remiges Ventures General Information
Company Description
Founded in 2014, Remiges Ventures is a venture capital firm based in Seattle, Washington. The firm seeks to invest in healthcare devices, healthcare supplies, life sciences, drug discovery, biotech, and pharmaceutical sectors.
Business Details
Website
www.remigesventures.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1201 3rd Avenue
- Suite 2200
- Seattle, WA 98101
- United States
Remiges Ventures Investments (36)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycomine | 14-May-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Restore Vision | 15-Apr-2026 | Drug Discovery | Clinical Trials - General | |||
| KUPANDO | 18-Mar-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Endurance Bio | 31-Dec-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Enemsa Pharma | 31-Dec-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Ride Health | 17-Dec-2025 | Other Healthcare Technology Systems | Generating Revenue | |||
| Eurus Therapeutics | 27-Jun-2025 | Drug Discovery | Startup | |||
| Sanodyne Therapeutics | 05-Jun-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| KisoJi Biotechnology | 29-Oct-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Immunis | 24-Oct-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Remiges Ventures Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| InFlectis BioScience | 24-Sep-2025 | Bankruptcy: Liquidation | |
| Mitoconix | 01-Jul-2019 |
Remiges Ventures Investments by Industry, Year, and Region
Remiges Ventures Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Kyoto University Innovation Capital | 3 |
|
|
||
| SMBC Venture Capital |
|
|
|||
| BioAdvance Capital (Conshohocken) |
|
|
|||
| Lumira Ventures |
|
|
|||
| Nippon Venture Capital |
|
|
Remiges Ventures FAQs
-
What is Remiges Ventures?
Founded in 2014, Remiges Ventures is a venture capital firm based in Seattle, Washington.
-
When was Remiges Ventures founded?
Remiges Ventures was founded in 2014.
-
Where is Remiges Ventures headquartered?
Remiges Ventures is headquartered in Seattle, WA.
-
What is Remiges Ventures's total asset value?
Remiges Ventures has around in total assets under management.
-
How many investments has Remiges Ventures made?
Remiges Ventures has made 36 investments.
-
What has Remiges Ventures invested in?
Remiges Ventures has made numerous investments in companies like Glycomine, Restore Vision, and KUPANDO within the Drug Discovery industry.
-
What has Remiges Ventures invested in recently?
Remiges Ventures's latest investment was on 14-May-2026 in Glycomine, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process